BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11133721)

  • 21. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.
    Weinstock DM; Ambrossi GG; Brennan C; Kiehn TE; Jakubowski A
    Bone Marrow Transplant; 2006 Mar; 37(6):539-46. PubMed ID: 16462755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limitations of EBV-PCR monitoring to detect EBV associated post-transplant lymphoproliferative disorder.
    Axelrod DA; Holmes R; Thomas SE; Magee JC
    Pediatr Transplant; 2003 Jun; 7(3):223-7. PubMed ID: 12756048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.
    Dutta R; Miao SY; Phan P; Fernandez-Pol S; Shiraz P; Ho D; Mannis GN; Zhang TY
    J Med Case Rep; 2021 Mar; 15(1):170. PubMed ID: 33773605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients.
    Tsai DE; Nearey M; Hardy CL; Tomaszewski JE; Kotloff RM; Grossman RA; Olthoff KM; Stadtmauer EA; Porter DL; Schuster SJ; Luger SM; Hodinka RL
    Am J Transplant; 2002 Nov; 2(10):946-54. PubMed ID: 12482147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated pleural PTLD after cardiac transplantation.
    Lamba M; Jabi M; Padmore R; Sengar DP; Veinot JP
    Cardiovasc Pathol; 2002; 11(6):346-50. PubMed ID: 12459436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level.
    Orii T; Ohkohchi N; Satomi S; Hoshino Y; Kimura H
    Transpl Int; 2002 Nov; 15(11):529-34. PubMed ID: 12461655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posttransplantation lymphoproliferative disorders in pediatric patients undergoing liver transplantation.
    Koh BY; Rosenthal P; Medeiros LJ; Osorio RW; Roberts JP; Ascher NL; Gelb AB
    Arch Pathol Lab Med; 2001 Mar; 125(3):337-43. PubMed ID: 11231479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin.
    Peterson MR; Emery SC; Yung GL; Masliah E; Yi ES
    Arch Pathol Lab Med; 2006 Feb; 130(2):176-80. PubMed ID: 16454557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus lymphoproliferative disorders after liver transplantation.
    Cao S; Cox KL
    Clin Liver Dis; 1997 Aug; 1(2):453-69, x-xi. PubMed ID: 15562578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
    Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients.
    Scheenstra R; Verschuuren EA; de Haan A; Slooff MJ; The TH; Bijleveld CM; Verkade HJ
    Transpl Infect Dis; 2004 Mar; 6(1):15-22. PubMed ID: 15225222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders.
    Jabs WJ; Hennig H; Kittel M; Pethig K; Smets F; Bucsky P; Kirchner H; Wagner HJ
    J Clin Microbiol; 2001 Feb; 39(2):564-9. PubMed ID: 11158107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjunctival tumor caused by Epstein-Barr virus-related infectious mononucleosis: Case report and review of literature.
    Vaivanijkul J; Boonsiri K
    Orbit; 2017 Apr; 36(2):91-94. PubMed ID: 28388350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disease.
    Ambinder RF
    Recent Results Cancer Res; 2021; 217():197-207. PubMed ID: 33200367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplantation of solid organ recipients shedding Epstein-Barr virus DNA pre-transplant: A prospective study.
    Verghese PS; Schmeling DO; Filtz EA; Grimm JM; Matas AJ; Balfour HH
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28915342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
    Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH
    J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance of Epstein-Barr virus loads in adult liver transplantation: associations with age, sex, posttransplant times, and transplant indications.
    Schaffer K; Hassan J; Staines A; Coughlan S; Holder P; Tuite G; McCormick AP; Traynor O; Hall WW; Connell J
    Liver Transpl; 2011 Dec; 17(12):1420-6. PubMed ID: 21837744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of quantitative EBV DNA measurements in cerebrospinal fluid for diagnosis and monitoring of treatment of central nervous system EBV-associated post-transplant lymphoproliferative disorder after allogenic hematopoietic stem cell transplantation.
    Bocian J; Januszkiewicz-Lewandowska D
    Ann Transplant; 2014 May; 19():253-6. PubMed ID: 24866354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.